Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Industrifonden in connection with its investment in InDex Pharmaceuticals
Mandate

Vinge advises Industrifonden in connection with its investment in InDex Pharmaceuticals

January 24, 2011

Vinge has advised Industrifonden in connection with its SEK 40 million investment in InDex Pharmaceuticals. InDex Pharmaceuticals develops Kappaproct, a drug developed for the treatment of severe inflammatory bowel disease. Further capital has also been raised from current shareholders, including SEB Venture Capital, which has invested an additional SEK 35 million. The financing will predominantly be used to conduct a clinical phase III trial using Kappaproct with the aim of obtaining market approval.

Vinge’s team consisted of, among others, project manager Johan Larsson and Petter Kjöllerström, who was responsible for the due diligence phase of the transaction. Johan Winnerblad was the responsible partner.

Related

Vinge advises HAKI Safety in connection with its divestment of Landqvist Mekaniska Verkstad to Opima

 Landqvist Mekaniska Verkstad is a mechanical engineering company specialising in metal machining and contract manufacturing, primarily serving Swedish industries. In 2024, it had annual sales of approximately SEK 78 M and an operating profit of SEK 9 M. The divestment is a step in HAKI Safety's change of strategy from a conglomerate to the current industry group with a focus on safety products and solutions that aim to create safe conditions for everyone working in challenging environments. Having completed this divestment, HAKI Safey now consists entirely of operations within work zone safety, scaffolding systems, and digital and technical solutions.
May 07, 2025

Vinge advises Main Capital and Pointsharp on the acquisition of Vemendo

 Vinge has advised Pointsharp International AB, an identity and access management software provider, on its acquisition of Vemendo AB (“Vemendo”). The strategic acquisition complements Pointsharp well and is in line with the company's growth strategy in the European identity and access management market.
May 07, 2025

Vinge advises Karl Hedin and the minority owners in connection with the sale of AB Karl Hedin Emballage to DTE

 Vinge has advised Karl Hedin and the minority owners in connection with the sale of AB Karl Hedin Emballage to Dansk Træemballage A/S (”DTE”).
May 07, 2025